COVID-19 neurologic manifestation
DOI:
https://doi.org/10.31053/1853.0605.v77.n2.28410Keywords:
covid-19, nervous system diseases, neuromuscular manifestations, guillain-barre syndromeAbstract
Dear Director: Reading your article "The pandemic due to the new covid-19 coronavirus", I would like to deepen the contributions of the symptoms of this disease. What has started as a pathology manifested by a respiratory syndrome such as atypical pneumonia, is currently associated with several non-respiratory manifestations (1). Guillain-Barré syndrome in a female traveler from Wuhan is one of the first reported neurological manifestations (2). The literature is rich in terms of headaches, seizures and strokes in seriously ill patients, although the first and last of these may be due to systemic complications of this novel coronavirus, a higher incidence of events has been reported in patients with a history of neurological manifestations. (3.4). One of the most recent manifestations reported is neuromuscular diseases. Guidon et al. criticize the lack of rigor in the reports on neuromuscular manifestations (4). If anything is certain, one manifestation of this pandemic is the large amount of information available in the scientific field, many of these without the same methodological rigor as before the pandemic, accentuating the responsibility of the reader to critically analyze all the information.Downloads
Download data is not yet available.
References
Eduardo,C. La pandemia por el nuevo coronavirus covid-19. Revista De La Facultad De Ciencias Médicas De Córdoba. 2020;77(1):1-3. [Internet]. [cited 2020 Apr 29]. Available from: https://revistas.unc.edu.ar/index.php/med/article/view/27935/29224
2. Zhao H, Shen D, Zhou H, Liu J, Chen S. Guillain-Barré syndrome associated with SARS-CoV-2 infection: causality or coincidence? Vol. 19, The Lancet Neurology. Lancet Publishing Group; 2020. p. 383–4.
3. Herman C, Mayer K, Sarwal A. Scoping review of prevalence of neurologic comorbidities in patients hospitalized for COVID-19. Neurology [Internet]. 2020 Apr 28 [cited 2020 Apr 29];10.1212/WNL.0000000000009673. Available from: http://www.neurology.org/lookup/doi/10.1212/WNL.0000000000009673
4. Guidon AC, Amato AA. COVID-19 and neuromuscular disorders. Neurology. 2020 Apr 13;10.1212/WNL.0000000000009566.
2. Zhao H, Shen D, Zhou H, Liu J, Chen S. Guillain-Barré syndrome associated with SARS-CoV-2 infection: causality or coincidence? Vol. 19, The Lancet Neurology. Lancet Publishing Group; 2020. p. 383–4.
3. Herman C, Mayer K, Sarwal A. Scoping review of prevalence of neurologic comorbidities in patients hospitalized for COVID-19. Neurology [Internet]. 2020 Apr 28 [cited 2020 Apr 29];10.1212/WNL.0000000000009673. Available from: http://www.neurology.org/lookup/doi/10.1212/WNL.0000000000009673
4. Guidon AC, Amato AA. COVID-19 and neuromuscular disorders. Neurology. 2020 Apr 13;10.1212/WNL.0000000000009566.
Published
2020-05-10
How to Cite
1.
Ocampo Rojas SJ. COVID-19 neurologic manifestation. Rev Fac Cien Med Univ Nac Cordoba [Internet]. 2020 May 10 [cited 2024 Jul. 16];77(2):130. Available from: https://revistas.unc.edu.ar/index.php/med/article/view/28410
Issue
Section
Cartas al Director
License
The Faculty of Medical Sciences Journal (RFCM) subscribes to the Open Access policy and does not charge authors fees for publishing, nor does it charge readers fees for accessing published articles (APC).